ATG16L1 and colitis: Reduced NOD2 activation has been shown to inhibit autophagy in DCs altering both bacterial trafficking and MHCII-dependent antigen presentation.41 Our preliminary data may suggest that, in turn, reduced ATG16L1 function may inhibit bacterial dependent activation of NOD2, thereby altering the susceptibility to colitis.